Información*
| Nombre | CRISELDA MENDOZA MILLA |
|---|---|
| Área | MEDICINA Y CIENCIAS DE LA SALUD |
| Campo | MEDICINA Y CIENCIAS DE LA SALUD |
| Disciplina | OTRAS ESPECIALIDADES MÉDICAS |
| Especialidad | OTRAS |
| CVU | 75092 |
| Institución | |
|---|---|
| Dependencia | SIN INFORMACIÓN |
| Entidad | CIUDAD DE MEXICO |
| Nivel | 1 |
| Vigencia | Inicio: 01/01/2025 |
| Fin: 31/12/2029 |
* Información del primer trimestre de 2026.
Fuente: SECIHTI.
Publicaciones ORCID
- 2024
- Time-Course and Fraction Analysis in Western Blot Reveals Improved Approaches for Evaluating Neutrophil Extracellular Trap-Associated Proteins
- 2022
- Zinc Oxide Nanoparticles Induce Toxicity in H9c2 Rat Cardiomyoblasts International Journal of Molecular Sciences
- Differential Leukocyte Expression of <i>IFITM1</i> and <i>IFITM3</i> in Patients with Severe Pandemic Influenza A(H1N1) and COVID-19 Journal of Interferon & Cytokine Research
- Failure to EGFR-TKI-based therapy and tumoural progression are promoted by MEOX2/GLI1-mediated epigenetic regulation of EGFR in the human lung cancer European Journal of Cancer
- 2021
- Mitochondrial Dysfunction and Alterations in Mitochondrial Permeability Transition Pore (mPTP) Contribute to Apoptosis Resistance in Idiopathic Pulmonary Fibrosis Fibroblasts International Journal of Molecular Sciences
- Expression of Surfactant Protein D Distinguishes Severe Pandemic Influenza A(H1N1) from Coronavirus Disease 2019 The Journal of Infectious Diseases
- Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1) Frontiers in Immunology
- LncRNA SOX2‐OT regulates AKT/ERK and SOX2/GLI‐1 expression, hinders therapy, and worsens clinical prognosis in malignant lung diseases Molecular Oncology
- Mesenchymal–Epithelial Transition in Fibroblasts of Human Normal Lungs and Interstitial Lung Diseases Biomolecules
- CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome Frontiers in Immunology